StudyFinder

MT2025-13 Long-term Follow-up of Subjects Who Received TRX103 in a Clinical Study Sponsored by Tr1X, Inc

Status: Recruiting

This study will enroll people who receive TRX103 as part of a separate research study, in order to monitor these patients for long-term safety, and discover more about the long-term effects of TRX103.

I'm interested

Sex: Male or Female
Age Group: 18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• have received TRX103 in a clinical study and have either completed the study or have discontinued early from the study
Exclusion Criteria:

• withdrawal from a clinical study before infusion of TRX103
Conditions:

Cancer

Keywords:

Clinics and Surgery Center (CSC)

Study Contact: Delaney Anderson - and05415@umn.edu
Principal Investigator: Mark Juckett
IRB Number: STUDY00025462

Back